EFFECT OF FERMENTED CHUB MACKEREL EXTRACT ON LIPID METABOLISM OF DIABETIC RATS U. Santoso1, S. Ishikawa2 and K. Tanaka2
1Faculty of Agriculture, Bengkulu University, Bengkulu - Indonesia.2Division of Bioresources and Bioproduction, Graduate School of Agriculture, Hokkaido University, Sapporo 060-0809 - JapanCorresponding E-mail: [email protected]Received January 26, 2010; Accepted July 28, 2010 ABSTRACT
The present study was conducted to evaluate the effect of fermented chub mackerel extract
(FCME) on lipid metabolism in diabetic rats. Four week-old male Wistar rats were divided into threegroups based on weight. All rats were induced with diabetes mellitus by single intraperitoneal injectionof streptozotocin at 45 mg/kg body weight. Thereafter, they were randomly distributed to threetreatments with 7 rats assigned to each treatment. One group was the control with no additive, and two-treatment groups were given the purified diets supplemented with 1% or 2% FCME. Experimentalresults showed that in comparison to the control, diabetic rats fed FCME increased feed intake (P<0.01)and body weight gain (P<0.05). FCME inclusion significantly reduced the activities of acetyl-CoAcarboxylase (P<0.01) and fatty acid synthetase (P<0.05) in diabetic rats. FCME significantly increasedcholesterol 7 -hydroxylase with no effect on HMG-CoA reductase activity. FCME had no effect onhepatic triglyceride, free cholesterol and phospholipid. FCME inclusion at 1% level significantlyreduced serum triglyceride. FCME significantly increased HDL-cholesterol (P<0.05) with no effect onLDL + VLDL-cholesterol, and significantly reduced atherogenic index. FCME did not significantlyaffect serum insulin and glucose concentration. In conclusion, FCME supplementation altered lipidmetabolism in diabetic rats. FCME supplementation reduced the risk of atherosclerosis in diabetic rats.
Keywords: fermented chub mackerel extract, lipid metabolism, diabetic ratINTRODUCTION
and a significant higher LDL/HDL-c ratio. Furthermore, they stated that the difference in
Diabetic mellitus is a state of nutritional state
lipoprotein profile per se may be the cause of
of nutritional starvation which frequently results
increased atherosclerosis in diabetic swines. In
in severe metabolic imbalance and pathological
addition, the lack of insulin action combined with
change in many tissues (Inui et al., 2000). In
the effect of glucocorticoids also the LDL
relation to lipid metabolism, diabetic condition is
receptor in the liver (Schneider, 1991) resulting
characterized by increases both fatty acid and
lower removing the major proportion of IDL and
cortisol. Consequently this could account for why
VLDL secretion is increased in ketotic type I
hypercholesterolemia. Duchateau et al. (2000)
diabetes, which is caused by insulin deficiency
found that there was significantly increases in
(Brindley, 1991). Hypersecretion of VLDL cause
plasma apo L level, cholesterol and triglyceride in
hypertriglyceridemia. Other dyslipidemia includes
low HDL-cholesterol, and small, dense LDL. The
Some investigations have been conducted to
incidence of atherosclerosis is 3-4 times greater in
lower obesity in diabetic animals. Dixon et al.
diabetics than non-diabetics at comparable plasma
(2002) found that atorvastatin (80 mg/day)
total cholesterol. Beyond total cholesterol
inclusion protected diabetic swine against
concentration, lipid abnormalities in the plasma of
coronary artery atherosclerosis. This protection
diabetics include elevated triglyceride, decrease
was in part caused by reduced plasma triglyceride
HDL-c levels, and the presence of small dense
concentration since other lipid parameters,
LDL. Dixon et al. (2002) found that the diabetic
swine had a higher and broader IDL/LDL peak
affected. Georgopoulos et al. (1998) found that a
J.Indonesian Trop.Anim.Agric. 35(3) September 2010
high monounsaturated fatty-acid enriched diet is
not preferable to a high-carbohydrate diet in
patients with type 1 Diabetes mellitus with regard
Kanzaki Company, Ltd., Takamatsu, Japan. The
to the occurrence of postprandial lipemia. Higashi
main constituents of this extract are peptides with
et al. (2002) found that oleic acid enriched diet
20-50 chain-length amino acids. This product
was associated with increased formation of post-
contains 39,6% moisture, 51.1% crude protein,
prandial chylomicron remnants compared with the
0.0% crude fat, 0.0% crude fiber, 8.7% crude ash
linoleic acid enriched diet in patients with type 2
and 0.6% nitrogen free extract (NFE). Amino acid
Diabetes mellitus. We recently found that
fermented chub mackerel extract was effective to
reduce lipid profiles in growing chicks (Tanaka et
Blood samples were drawn from tail arterial
al., 1990), broiler chicks (Tanaka et al., 1992) and
under ether narcosis before and every weeks after
rats (Santoso et al., 2000; 2001). This FCME was
given streptozotocin, and left in an ice water to
known to be rich in peptides. Peptides were
prevent glucose degradation. The serum was
cholesterol-enriched cells, activate the plasma
centrifugation. Simultaneously glucose excretion
LCAT and to protect against atherosclerosis
to urine confirmed by test paper (Testepe,
(Garber et al., 2001). Therefore, it was assumed
that FCME inclusion to the diet would reduce
At the end of experimental period, all rats
lipid profiles in diabetic animals. Therefore, the
were weighed individually. Thereafter, blood
present study was conducted to evaluate effect of
samples were drawn from heart and removed the
FCME on lipid metabolism in diabetic rats.
liver under ether narcosis. The serum stored at–30oC until the determination of glucose, insulin,
MATERIALS AND METHODS
total cholesterol, HDL-cholesterol and lipidfractions.
described (Santoso et al., 1995). The activities of
experiment were purchased from Japan SLC Inc
(Hamamatsu, Shizuoka, Japan). They were then
weighed individually and divided into three
Coenzyme A carboxylase (E.C. 6.2.1.3) activity
groups based on weight. All rats were induced
was assayed by H14CO3-fixation method (Qureshi
with diabetes mellitus by single intraperitoneal
et al., 1980). Fatty acid synthetase (FAS) activity
injection of streptozotocin at 45 mg/kg body
incorporation method (HSU et al., 1965). The 3-
carbonyl)amino]-D-glucopyranose (given Sigma)
hydroxy-3-methylglutaryl-CoA reductase activity
at 0.1 M citrate buffer solution, pH 4.5}.
was assayed by the method of Shefer et al.
Thereafter, they were randomly distributed to
(1973). The protein content of the solution used
three treatments with 7 rats assigned to each
for enzyme assay was determined by the method
treatment. One group was the control with no
of Lowry et al. (1951) using bovine serum
additive, and two-treatment groups were given the
albumin as the standard. ACC and FAS activities
purified diets supplemented with 1% or 2%
FCME. The rats were raised to 7 weeks of age in
converted to product per minute per milligram of
individual cages in an air-conditional room
protein at 37oC. 3-hydroxy-3-methylglutaryl-CoA
(temperature 22+2oC with humidity 50 to 60%)
reductase activity was expressed as picomole of
with the light on from 08:00 to 20:00. Rats were
substrate converted to product per minute per mg
fed a commercial nonpurified diet (type CE-2,
protein at 38oC. Cholesterol 7-hydroxylase was
Japan Clea) for a week before the initiation of the
expressed as nmol/hour/mg protein. Samples were
experiment with purified diets. The composition
of experimental diets is shown in Table 1. Feed
The lipid fractions were separated by thin-
and water were provided for ad libitum
layer chromatography on silica gel chromarod
consumption. To confirm the induction of diabetes
using hexane-diethylether-formic acid (60:10:1)
mellitus, the serum glucose level in the fasting
and hexane-benzene (1:1) as developing solvent
state (16-hours starvation) was determined by
and quantified by IATROSCAN TH-10 TLC/FID
using a commercial kit (Glucose CII-Test Wako
Analyzer (Iatron Laboratories, Inc., Tokyo,
Lipid Metabolism of Diabetic Rat (U. Santoso, et al.)
Table 1. Composition of Experimental Diet (%)
1) Supplied 650.0 g CaHP O4, 160.0 g NaCl, 140.0 g K2CO3, 32.7 g MgCO3, 10.0 g FeSO4. 7H2O, 3 .0 g Mn SO4 . H2 O, 1 .0 g CoCl2 . 6 H2 O, 1 .0 g CuSO4 , 2 .0 g Zn CO3 , 0 .1 g KI an d 0 .2 g NaF p er 1 kg.
2) Supplied 0.10 g retinyl acet at e, 0.00005 g cholecalciferol and 0.8995 g corn starch per 1 gram mixture. 3) Supplied 0.083 g thiamine-HCl, 0.233 g riboflavine, 0.833 g niacin, 0.75 g Ca-pantothenate, 0.1 g p yrido xin e-HCl, 0 .0 58 g fo lic acid, 1 5 g in osit o l, 1 .6 6 7 g p -amino ben zo ic acid, 0 .00 5 g bio t in , 0 .0 0 4 g
cy an o co balamin, 3 3 .3 3 3 g ch o lin e-HCl, 0 .33 3 g menadio ne and 4 7.5 99 co rn st rach p er 10 0 g mix t ure.
fatty acid synthetase were significantly lower in
Concentrations of serum total cholesterol,
diabetic rats fed FCME, whereas cholesterol 7
HDL-cholesterol were measured with commercial
kits (Cholesterol E Test Wako Kit and HDL-
(P<0.01). The activity of HMG-CoA reductase
cholesterol E Test Wako Kit from Wako Junyaku
was not significantly affected (Table 4).
Kogyo Co. LTD). The difference between the total
FCME had no effect on hepatic triglyceride,
cholesterol and HDL-cholesterol was assumed to
triglyceride was significantly lower in rats fed diet
Fudamoto, 1995). An atherogenic index was
with FCME (P<0.01), but total cholesterol and
measured using equation published by Nishizawa
free cholesterol were not significantly influenced.
increased (P<0.05) with lower atherogenic index
response variables using one-way ANOVA in
(P<0.05). Mackerel extract had no effect on
which the overall treatment differences were
LDL+VLDL-cholesterol concentration (Table 5).
represented by single orthogonal contrasts
Dietary FCME had no effect on serum insulin.
between control and treatment groups (Shinjo,
However, 2% FCME inclusion tended to increase
insulin concentration at 24.4% level. DISCUSSION
FCME inclusion significantly increased feed
intake (P<0.01) and body weight gain (P<0.05)
from higher feed intake in FCME group. It is
FCME had no effect on liver weight (Table 2).
possible that streptozotocin eliminated the
advantage of FCME in improving feed conversion
concentration of serum glucose (Table 3).
ratio. It is unkown why feed intake of diabetic rats
The activities of acetyl-CoA carboxylase and
J.Indonesian Trop.Anim.Agric. 35(3) September 2010
Table 2. Effects of Fermented Chub Mackerel Extract on Feed Intake, Body WeightGain and Feed Conversion Ratio of Diabetic Rats
Mean+SD for 7 rats * Significantly different (P<0.05) from the control group. ** Significantly different (P<0.01) from the control group. *** Significantly different (P<0.001) from the control group.
Table 3. Effects of Fermented Chub Mackerel Extract on
without cholesterol or those fed high-cholesterol
Concentration of Glucos e in the Serum of Diabetic Rats
containing diet. A reduced in hepatic fatty acidsynthesis is a major factor which caused lower
hepatic triglyceride synthesis (Scorve et al.,
1993), and resulting in lower triglyceride
secretion into circulation. This may explain lower
serum triglyceride in diabetic rats fed 1% FCME.
It is unkown however, although feeding 2%
FCME reduced hepatic acetyl-CoA carboxylase
and fatty acid synthetase activities it resulted in
higher serum triglyceride concentration and no
change in hepatic triglyceride. It was known that amajor site of fatty acid synthesis in rats was inadipose tissues. Therefore, it is needed to evaluate
correlation between serum glucose and feed
the activity of acetyl-CoA carboxylase and fatty
intake (r = -0.93), it appear that the higher feed
acid synthetase in adipose tissue to elucidate the
intake could not fully be explained by lower
serum glucose concentration. It was known that
triglyceride. In addition, triglyceride clearance
FCME rich in glutamic acid, one of an active taste
from the circulation by lipoprotein lipase may
compounds in feed that may also improve the
palatability of diet, and therefore it increased feed
intake. As far as growth efficiency concerned, the
inclusion of FCME in diabetic rats had no
observation that in rats the liver exhibits high
beneficial effect. The present results agree with
rates of cholesterol synthesis whereas nonhepatic
the observation of Santoso et al. (2000) who
tissues other than intestine show rates that are less
found that FCME inclusion had a little value on
than 5% of those in the liver (Balasubramaman et
improving feed efficiency in rats fed cholesterol-
al., 1976). FCME inclusion did not reduce the
activity of hepatic HMG-CoA reductase, a rate
Acetyl-CoA carboxylase was suggested as a
limiting enzyme in cholesterol synthesis.
rate limiting enzyme in fatty acid synthesis
Therefore, FCME inclusion might have no effect
(Brindley, 1991). Therefore, the reduction of
on hepatic cholesterol synthesis. However, FCME
acetyl-CoA carboxylase activity in diabetic rats
inclusion might increase hepatic bile acid
fed FCME would result in lower fatty acid
synthesis as indicated by higher activity of hepatic
synthesis. Our previous studies (Santoso et al.,
cholesterol 7-hydroxylase activity, a rate
2000, 2001) also found that FCME inclusion
limiting enzyme in bile acid synthesis. An
resulted in lower acetyl-CoA carboxylase and
increase in hepatic bile acid synthesis, however,
fatty acid synthetase activities of rats fed diet
Lipid Metabolism of Diabetic Rat (U. Santoso, et al.)
Table 4. Effects of Fermented Chub Mackerel Extract on Activities of Lipogenic Related
Acetyl-CoA carboxylase (nmol/min/mg protein
Fatty acid synthetase (nmol/min/mg protein
Choles terol 7-hydroxylas e (nmol/hr/mg protein
1Mean + SD for 7 rats; *Significantly different (p<0.05) from the control group. ** Significantly different (p<0.01) from the control group.
Table 5. Effects of Fermented Chub Mackerel Extract on
the risk of atherosclerosis. In our previous results
Various Lipid Fractions and Insulin of Diabetic Rats
(Santoso et al., 2000) also showed that whenFCME was supplemented to a high-cholesterol
containing diet, an increase in serum HDL-
cholesterol with lower LDL-cholesterol without
any change in total cholesterol was observed.
Lower atherogenic index found in rats fed FCME
indicated that FCME inclusion might reduce the
risk of atherosclerosis in diabetic rats.
indicated by no effect of FCME on serum glucose
CONCLUSION
As far as growth efficiency concerned, the
Atherogenix index2 0.50+0.10 0.35+0.05** 0.39+0.07*
inclusion of FCME in diabetic rats had no
beneficial effect. FCME supplementation reduced
the activities of hepatic acetyl-CoA carboxylase
2(Total cholesterol – HDL-cholesterol)/HDL-cholesterol
and fatty acid synthetase, but it increased the
*Significantly different (p<0.05) from the control group
activity of hepatic cholesterol 7-hydroxylase in
** Significantly different (p<0.01) from the control group
diabetic rats. FCME supplementation reduced therisk of atherosclerosis as indicated by loweratherogenic index.
was not accompanied by neither lower hepaticcholesterol nor serum total cholesterol. No changein hepatic or serum cholesterol in rats fed FCME
REFERENCES
was in agreement with the observation of Santosoet al. (2001).
Badimon, J. J., L. Badimon and V. Fuster. 1990.
A protective effect against the development
Regression of aherosclerotic lesions by high
of atherosclerotic disease is attributed to HDL-
density lipoprotein plasma fraction in the
cholesterol on the basis of their key roles in
cholesterol-fed rabbit. J. Clin. Invest.,
reverse cholesterol transport and also their
antioxidant properties. Badimon et al. (1990) also
Balasubramanian, S., J. L. Goldstein, J. R. Faust
found that injection of HDL into rabbits fed on
atherogenic diet has been shown to inhibit
atherosclerotic lesion formation. Therefore, an
increase in HDL-cholesterol with tendency of
cholesterol synthesis in nonhepatic tissues of
lower LDL-cholesterol by FCME in the present
rat. Proc. Natl. Acad. Sci. 73:2564-2568.
study might have beneficial impact on reducing
J.Indonesian Trop.Anim.Agric. 35(3) September 2010
Lowry, O. H., N. J. Rosebrough, A. L. Fart and R.
triacylglycerols. In: Biochemistry of Lipids,
J. Randell. 1951. Protein measurement with
Lipoproteins and Membranes (Vance, D. E.
folin phenol reagent. J. Biol. Chem. 193:265-
Dixon, J. L., S. Shen, J. P. Vuchetich, E.
Mattson, F. H. and S. M. Grundy. 1985.
Wysocka, G. Y. Sun and M. Sturek. 2002.
Comparison of effects of dietary saturated,
monounsaturated and polyunsaturated fatty
dyslipidemic swine protection by atorvastatin
acid on plasma lipids and lipoproteins in
involves decreased VLDL triglycerides but
minimal effects on the lipoprotein profile. J.
Miller, G. S., and N. F. Miller. 1975. Plasma high
Duchateau, P. N., I. Movsesyan, S. Yamashita, N.
ischemic heart disease. Lancet 1:16-19.
Sakai, K. Hirano, S. A. Schoenhaus, P. M.
O’connor-Kearns, S. J. Spencer, R. B. Jafte,
evelation of plasma concentration of high-
R. F. Redberg, B. Y. Ishida, Y. Matsuzawa, J.
density lipoprotein cholesterol in mice fed
with protein from proso millet. Biosci.
apolipoprotein L concentrations correlate
Qureshi, A. A., W. C. Burger, N. Prentice, H. R.
levels in normolipidemic, hyperlipidemic and
Bird and M. L. Sunde. 1980. Regulation of
diabetic subjects. J. Lipid Res. 41:1231-1236.
lipid metabolism in chicken liver by dietary
Garber, D. W., G. Datta, M. Chaddha, M. N.
Palgunachari, S. Y. Hama, M. Navab, A. M.
Santoso, U., M. Ishikawa and K. Tanaka. 2000.
Effects of fermented chub mackerel extract
Anantharamaiah. 2001. A new synthetic class
cholesterol diet. Asian-Aust. J. Anim. Sci. 13:
mice from diet-induced atherosclerosis. J.
Santoso, U., S. Ishikawa and K. Tanaka. 2001.
Georgopoulos, A., J. P. Bantle, M. Noutson, W. R.
Effect of fermented chub mackerel extract on
Swaim and S. J. Parker. 1998. Differences in
lipid metabolism of rats fed diet without
the metabolism of postprandial lipoproteins
cholesterol. Asian-Aust. J. Anim. Sci. 14:
after a high-monounsaturated-fat vs a high-
carbohydrate diet in patients with type 1
Schneider, W. J. 1991. Removal of lipoproteins
diabetes mellitus. Arteriocler. Thromb. Vasc.
Lipoproteins and Membranes (Vance, D. E.
Higashi, K., M. Shige, T. Ito, K. Nakajima, T.
Ishikawa, H. Nakamura and F. Ohsuzu. 2002.
Shefer, S., S. Hauser, L. Lapar and E. H. Mosbch.
Effect of a low-fat diet enriched with oleic
1973. Regulatory effects of dietary sterols
acid on postprandial lipemia in patients with
and bile acids on rat intestinal 3-hydroxy-3-
type 2 diabetes mellitus. Lipids 36: 1-6.
methylglutaryl-CoA reductase. J. Lipid Res.
Hsu, R. Y., G. Wasson and J. W. Porter. 1965. The
purification and properties of the fatty acid
Shinjo, A. 1990. First Course in Statistics.
synthetase of pigeon liver. J. Biol. Chem.
Laboratory of Animal Breeding, College of
Agriculture, University of the Ryukyus.
Inui, H., R. Yasuno, M. Takenoshita, Y. Ohnishi,
M. Sakamoto, J. Matsuzaki, R. Yamaji, K.
Spady, D. K. and J. M. Dietschy. 1985. Dietary
Miyatake, A. Yamatodani and Y. Nakano.
saturated triacylglycerols suppress hepatic
low-density lipoprotein transport in hamster.
decarboxylase activity and plasma gastrin
Tanaka, K., B. S. Youn, S. Ohtani and M.
diabetic rats. J. Nutr. Sci. Vitaminol. 46:144-
Sakaida. 1990. Effects of fermented product
Kannel, W. B.,and D. L. Mcgee. 1979. Diabetes
lipogenesis and contents of various lipids in
and cardiovascular disease: The Framingham
the liver of growing chicks. Jpn. J. Zootech.
study. J. Am. Med. Assoc., 241:2035-2038. Lipid Metabolism of Diabetic Rat (U. Santoso, et al.)
Tanaka, K., B. S. Youn, U. Santoso, S. Ohtani and
broilers. Anim. Sci. Technol. 63:32-37.
Vega, G. L., F. Grosjek, R. Wolf and S. M.
Grundy. 1962. Influence of polyunsaturated
fats on composition of plasma lipoproteins
lipogenesis and on contents of various lipid
and apolipoproteins. J. Lipid Res. 23:811-822
fractions in the liver and the thigh muscle of
J.Indonesian Trop.Anim.Agric. 35(3) September 2010
Are you taking or have you taken any of the following? Yes No Drugs for osteoporosis such as Fosomax or Boniva List any medications that you are taking. Dental History (circle appropriate answer) Yes No Do you have regular dental checkups? Date of last exam: Yes No Have you had any trouble with previous dental treatment? Explain: Yes No Do you want to keep your own teeth for yo
Terry L. Simpson, M.D., FACS ARIZONA SURGICAL PLAZA I 1840 W. Maryland Suite A Phoenix, Arizona 85015 Phone (602) 234-8995 Fax (602) 230-8344 Email: [email protected] Website: http://drsimpson.net Post-op Instructions Please call 602-234-8995 for any questions or concerns Call the office if you experience any of the following: • Shortness of bre